Jason Campagna, Chief Medical Officer at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 154 shares at $119.45 ($18K) on 2019-12-19, disclosed to the SEC on 2019-12-20.
Scheduled sale ($18k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |